Product Pipeline

/Product Pipeline
Product Pipeline 2019-03-22T10:39:19+00:00

Immuno-oncology targets

TARGET NAME DISEASE INDICATIONS CURRENT STATUS PROJECTION

ZM008

*New target. Functions through NK cell based therapy

Germinal B cell lymphoma, glioma, hepatocellular carcinoma, prostate cancer In-vivo study completed

Preclinical study – 2019

Ph I study – 2019

ZM012

mAb target. Functions through tumour associated antigen/NK cell receptor

Lymphoma and other Undisclosed indications Unique Clone identification in process Under Development

ZM014

mAb target. Functions through tumour NK cell receptor

Lymphoma Unique Clone identification in process Under Development

2

Molecules for NK cell and cell targets under development

Future targets of interest

T Reg Cells

Novel Targets

Academic collaboration in the US